Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Reviva Pharmaceuticals Q3 EPS $(0.06) Beats $(0.10) Estimate

Author: Benzinga Newsdesk | November 13, 2025 04:34pm
Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.10) by 38.78 percent. This is a 76 percent increase over losses of $(0.25) per share from the same period last year.

Posted In: RVPH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist